InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Sangiovanni Timothy J.. Director active across 1 company, notably ZEVRA THERAPEUTICS, INC.. In total, 5 disclosures have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €50k. Activity tracked since 10 March 2023. The latest transaction was filed on 3 February 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Sangiovanni Timothy J. is SVP, Finance & Corp Controller at ZEVRA THERAPEUTICS, INC. He has 5 filings in total, and across the sampled recent filings the period runs from 2023-03-13 to 2026-02-04, with buy volume of EUR 4302 and sell volume of EUR 46046, and the modal transaction nature is Disposition.